Company Filing History:
4 out of 1,151 
3 out of 26 
1 out of 1 Years Active: 2010-2025
Title: The Innovative Contributions of Vanessa Soros
Introduction
Vanessa Soros is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of biotechnology. With a total of nine patents to her name, she has made remarkable advancements in the development of modified polypeptides that play a crucial role in medical treatments.
Latest Patents
One of her latest patents involves modified urokinase-type plasminogen activator polypeptides and methods of use. This invention provides nucleic acid molecules, including vectors and plasmids, that encode modified u-PA polypeptides and fusion proteins. These polypeptides are designed to have altered activity and specificity, enabling them to cleave complement proteins, such as complement protein C3, thereby inhibiting complement activation. This technology has potential applications in treating various diseases and conditions mediated by complement activation, including ischemic disorders, autoimmune diseases, and inflammatory conditions.
Another significant patent focuses on nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use. The modified MTSP-1 polypeptides are engineered to inhibit complement activation, which is crucial in treating diseases where complement activation plays a role. This includes conditions such as myocardial infarction, stroke, and age-related macular degeneration.
Career Highlights
Throughout her career, Vanessa Soros has worked with leading companies in the biotechnology